An Overview of Rett Syndrome

Kristen L. Szabla, Lisa M Monteggia

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Rett syndrome (RTT) is a neurological disorder that is estimated to affect one in every 10,000 live female births -worldwide. In this chapter we discuss the hallmarks of RTT, as well as inheritance of the disease, its diagnostic -testing, evolution, variants, and end of life comorbidities. We describe the consequences of loss-of-function mutations in the gene encoding the transcription factor methyl-CpG binding protein 2 (MeCP2) in RTT, as well as discuss normal and abnormal MeCP2 gene products, genotype-phenotype correlations, and the search for MeCP2 gene -targets. Finally, we provide an overview of current literature regarding pathology in human RTT subjects, MeCP2-based mouse models, alterations in brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 -(IGF-1) levels in RTT individuals and in MeCP2-based mouse models, as well as recent progress in the search for rational therapeutic interventions.

Original languageEnglish (US)
Title of host publicationRosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition
PublisherElsevier Inc.
Pages171-182
Number of pages12
ISBN (Print)9780124105294, 9780124105492
DOIs
StatePublished - Nov 13 2014

Fingerprint

Rett Syndrome
Methyl-CpG-Binding Protein 2
Brain-Derived Neurotrophic Factor
Live Birth
Genetic Association Studies
Somatomedins
Nervous System Diseases
Insulin-Like Growth Factor I
Genes
Comorbidity
Transcription Factors
Pathology
Mutation
Proteins

Keywords

  • BDNF
  • MeCP2
  • Neurodevelopmental disorder
  • Rett syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Szabla, K. L., & Monteggia, L. M. (2014). An Overview of Rett Syndrome. In Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition (pp. 171-182). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-410529-4.00016-4

An Overview of Rett Syndrome. / Szabla, Kristen L.; Monteggia, Lisa M.

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. Elsevier Inc., 2014. p. 171-182.

Research output: Chapter in Book/Report/Conference proceedingChapter

Szabla, KL & Monteggia, LM 2014, An Overview of Rett Syndrome. in Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. Elsevier Inc., pp. 171-182. https://doi.org/10.1016/B978-0-12-410529-4.00016-4
Szabla KL, Monteggia LM. An Overview of Rett Syndrome. In Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. Elsevier Inc. 2014. p. 171-182 https://doi.org/10.1016/B978-0-12-410529-4.00016-4
Szabla, Kristen L. ; Monteggia, Lisa M. / An Overview of Rett Syndrome. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. Elsevier Inc., 2014. pp. 171-182
@inbook{51f65ddcd3f84e209abf22c35d81a2f9,
title = "An Overview of Rett Syndrome",
abstract = "Rett syndrome (RTT) is a neurological disorder that is estimated to affect one in every 10,000 live female births -worldwide. In this chapter we discuss the hallmarks of RTT, as well as inheritance of the disease, its diagnostic -testing, evolution, variants, and end of life comorbidities. We describe the consequences of loss-of-function mutations in the gene encoding the transcription factor methyl-CpG binding protein 2 (MeCP2) in RTT, as well as discuss normal and abnormal MeCP2 gene products, genotype-phenotype correlations, and the search for MeCP2 gene -targets. Finally, we provide an overview of current literature regarding pathology in human RTT subjects, MeCP2-based mouse models, alterations in brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 -(IGF-1) levels in RTT individuals and in MeCP2-based mouse models, as well as recent progress in the search for rational therapeutic interventions.",
keywords = "BDNF, MeCP2, Neurodevelopmental disorder, Rett syndrome",
author = "Szabla, {Kristen L.} and Monteggia, {Lisa M}",
year = "2014",
month = "11",
day = "13",
doi = "10.1016/B978-0-12-410529-4.00016-4",
language = "English (US)",
isbn = "9780124105294",
pages = "171--182",
booktitle = "Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - An Overview of Rett Syndrome

AU - Szabla, Kristen L.

AU - Monteggia, Lisa M

PY - 2014/11/13

Y1 - 2014/11/13

N2 - Rett syndrome (RTT) is a neurological disorder that is estimated to affect one in every 10,000 live female births -worldwide. In this chapter we discuss the hallmarks of RTT, as well as inheritance of the disease, its diagnostic -testing, evolution, variants, and end of life comorbidities. We describe the consequences of loss-of-function mutations in the gene encoding the transcription factor methyl-CpG binding protein 2 (MeCP2) in RTT, as well as discuss normal and abnormal MeCP2 gene products, genotype-phenotype correlations, and the search for MeCP2 gene -targets. Finally, we provide an overview of current literature regarding pathology in human RTT subjects, MeCP2-based mouse models, alterations in brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 -(IGF-1) levels in RTT individuals and in MeCP2-based mouse models, as well as recent progress in the search for rational therapeutic interventions.

AB - Rett syndrome (RTT) is a neurological disorder that is estimated to affect one in every 10,000 live female births -worldwide. In this chapter we discuss the hallmarks of RTT, as well as inheritance of the disease, its diagnostic -testing, evolution, variants, and end of life comorbidities. We describe the consequences of loss-of-function mutations in the gene encoding the transcription factor methyl-CpG binding protein 2 (MeCP2) in RTT, as well as discuss normal and abnormal MeCP2 gene products, genotype-phenotype correlations, and the search for MeCP2 gene -targets. Finally, we provide an overview of current literature regarding pathology in human RTT subjects, MeCP2-based mouse models, alterations in brain-derived neurotrophic factor (BDNF) and insulin-like growth factor 1 -(IGF-1) levels in RTT individuals and in MeCP2-based mouse models, as well as recent progress in the search for rational therapeutic interventions.

KW - BDNF

KW - MeCP2

KW - Neurodevelopmental disorder

KW - Rett syndrome

UR - http://www.scopus.com/inward/record.url?scp=84943247544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943247544&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-410529-4.00016-4

DO - 10.1016/B978-0-12-410529-4.00016-4

M3 - Chapter

AN - SCOPUS:84943247544

SN - 9780124105294

SN - 9780124105492

SP - 171

EP - 182

BT - Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition

PB - Elsevier Inc.

ER -